logo

Video encyclopedia

Nivolumab

1:04

The safety of nivolumab for advanced melanoma

4:43

Nivolumab in Renal Cell Carcinoma

3:47

Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer

1:55

Neoadjuvant ipilimumab plus nivolumab in stage III melanoma

5:19

FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...

Nivolumab, marketed as Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Explore contextually related video stories in a new eye-catching way. Try Combster now!
  • Medical use 

  • Side effects 

  • Physical properties 

  • History 

  • Research